Precision Oncology

Information about precision oncology and advancements in the fields
76 Pins
·
3y
Non Small Cell Lung Cancer Prognosis
Prognosis for Non-small cell lung cancer (NSCLC) depends on several factors, but most importantly, the stage of disease. Nearly half of all #NSCLC cases are diagnosed in advanced stages, which worsens the overall prognosis. Testing for biomarkers can identify any targeted therapies that can be used for treatment and in some cases, improve the prognosis. For advanced stage patients and those seeking new treatments, #clinicaltrials are an option to improve quality of life. #lungcancer #massivebio
Clinical Trials for TP53 Wild-Type Tumors
TP53 mutations occur in ovarian, esophageal, colorectal, head and neck, larynx, and lung cancers at a rate of 38-50 percent, while it occurs in 5 percent of cases of primary leukemia, sarcoma, testicular cancer, malignant melanoma, and cervical cancer. Confirming a TP-53 Wild-Type tumor can help decide which cancer treatment option may be the most effective for the patient. Learn more about TP53 Wild-Type Tumors and how they are being treated in #clinicaltrials. #massivebio #cancerresearch
What Are Common Targeted Therapies Used in Breast Cancer - Breast Cancer Pros
Targeted therapies locate cancer cells with DNA abnormalities known as mutations. Once testing confirms the presence of a mutation, #targetedtherapies can be used to attack those cells, which can be more effective than standard therapies and cause less side effects for breast cancer patients. Learn more about which therapies are used in #breastcancer below. #clinicaltrials #genomics #precisiononcology #cancerresearch
Primary Myelofibrosis - Myelofibrosis Clinical Trials
Primary myelofibrosis impairs the production of blood cells and fibrosis of the bone marrow. Cases vary from asymptomatic to more aggressive, causing anemia, fatigue, and bone pain. Learn more about the symptoms, diagnosis, and treatment of #myelofibrosis below. #MPN #PMF #bloodcancer #massivebio
Breast Cancer FGFR Clinical Trials
breast cancer mutations like FGFR help doctors understand more about the patient's prognosis. Also, most mutations have targeted therapies available for treatment, which target abnormalities in cancer cells while avoiding healthy cells. Clinical trials are available with new drugs targeting the FGFR mutation in breast cancer. Learn more about the treatment of FGFR #breastcancer. #massivebio #breastcancerawareness #clinicaltrials
Virtual Tumour Board
Second opinions are not enough for us. We bring expertise to you. Your Virtual Tumor Board is comprised of 3 or more physicians who gather and review all your medical history to offer an unbiased, expert analysis with recommendations for your cancer treatment. Schedule a free consultation with a patient advocate today. #virtual #tumorboard #massivebio
Career
We're hiring! We're looking for passionate team members to fill several openings that are currently available. If you'd like to join a hardworking team dedicated to helping cancer patients, we want to hear from you! Find out more and apply. #hiring #jobopportunities #careers #massivebio
Virtual Tumour Board
Are you looking for virtual cancer services during the COVID-19 pandemic? Look no further than the Virtual Tumor Board (VTB), A team of physicians from some of the top cancer institutes review a cancer case and deliver an unbiased and personalized expert-analysis. #Cancersupport #massivebio #PrecisionOncology https://video.buffer.com/v/5ff732b708fc413c61031702